AXON
Price
$708.84
Change
-$3.31 (-0.46%)
Updated
Sep 26 closing price
Capitalization
55.65B
39 days until earnings call
CVAC
Price
$5.37
Change
+$0.02 (+0.37%)
Updated
Sep 26 closing price
Capitalization
1.21B
51 days until earnings call
Interact to see
Advertisement

AXON vs CVAC

Header iconAXON vs CVAC Comparison
Open Charts AXON vs CVACBanner chart's image
Axon Enterprise
Price$708.84
Change-$3.31 (-0.46%)
Volume$442.85K
Capitalization55.65B
CureVac
Price$5.37
Change+$0.02 (+0.37%)
Volume$352.57K
Capitalization1.21B
AXON vs CVAC Comparison Chart in %
Loading...
AXON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CVAC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AXON vs. CVAC commentary
Sep 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AXON is a Hold and CVAC is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 28, 2025
Stock price -- (AXON: $708.84 vs. CVAC: $5.37)
Brand notoriety: AXON and CVAC are both not notable
AXON represents the Aerospace & Defense, while CVAC is part of the Biotechnology industry
Current volume relative to the 65-day Moving Average: AXON: 68% vs. CVAC: 63%
Market capitalization -- AXON: $55.65B vs. CVAC: $1.21B
AXON [@Aerospace & Defense] is valued at $55.65B. CVAC’s [@Biotechnology] market capitalization is $1.21B. The market cap for tickers in the [@Aerospace & Defense] industry ranges from $312.81B to $0. The market cap for tickers in the [@Biotechnology] industry ranges from $98.9B to $0. The average market capitalization across the [@Aerospace & Defense] industry is $23.22B. The average market capitalization across the [@Biotechnology] industry is $1.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AXON’s FA Score shows that 2 FA rating(s) are green whileCVAC’s FA Score has 2 green FA rating(s).

  • AXON’s FA Score: 2 green, 3 red.
  • CVAC’s FA Score: 2 green, 3 red.
According to our system of comparison, CVAC is a better buy in the long-term than AXON.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AXON’s TA Score shows that 4 TA indicator(s) are bullish while CVAC’s TA Score has 3 bullish TA indicator(s).

  • AXON’s TA Score: 4 bullish, 6 bearish.
  • CVAC’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, CVAC is a better buy in the short-term than AXON.

Price Growth

AXON (@Aerospace & Defense) experienced а -8.48% price change this week, while CVAC (@Biotechnology) price change was +0.37% for the same time period.

The average weekly price growth across all stocks in the @Aerospace & Defense industry was +1.25%. For the same industry, the average monthly price growth was +5.32%, and the average quarterly price growth was +57.23%.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.96%. For the same industry, the average monthly price growth was +9.24%, and the average quarterly price growth was +51.43%.

Reported Earning Dates

AXON is expected to report earnings on Nov 06, 2025.

CVAC is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Aerospace & Defense (+1.25% weekly)

Aerospace & Defense is one of largest industries in the U.S., mainly comprising the following areas: commercial airliners, military aircraft, missiles, space, and general aviation. Focused heavily on research & development, it is also one of the fastest growing industries. Military aircraft has the largest market share in the industry’s sales, followed by space systems, civil aircraft, and missiles. Aerospace exports, directly and indirectly, support more jobs than the export of any other commodity, according to a study by the U.S. Department of Commerce. Boeing Company, Lockheed Martin Corporation and General Electric Company are some of the most prominent players in this space.

@Biotechnology (+3.96% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AXON($55.6B) has a higher market cap than CVAC($1.21B). AXON has higher P/E ratio than CVAC: AXON (174.59) vs CVAC (5.32). CVAC YTD gains are higher at: 57.478 vs. AXON (19.269). AXON has higher annual earnings (EBITDA): 341M vs. CVAC (239M). AXON has more cash in the bank: 2.23B vs. CVAC (396M). CVAC has less debt than AXON: CVAC (36M) vs AXON (2.05B). AXON has higher revenues than CVAC: AXON (2.39B) vs CVAC (511M).
AXONCVACAXON / CVAC
Capitalization55.6B1.21B4,599%
EBITDA341M239M143%
Gain YTD19.26957.47834%
P/E Ratio174.595.323,284%
Revenue2.39B511M468%
Total Cash2.23B396M563%
Total Debt2.05B36M5,697%
FUNDAMENTALS RATINGS
AXON: Fundamental Ratings
AXON
OUTLOOK RATING
1..100
35
VALUATION
overvalued / fair valued / undervalued
1..100
89
Overvalued
PROFIT vs RISK RATING
1..100
11
SMR RATING
1..100
57
PRICE GROWTH RATING
1..100
48
P/E GROWTH RATING
1..100
11
SEASONALITY SCORE
1..100
90

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AXONCVAC
RSI
ODDS (%)
Bullish Trend 3 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 3 days ago
77%
Momentum
ODDS (%)
Bearish Trend 3 days ago
71%
Bullish Trend 3 days ago
67%
MACD
ODDS (%)
Bearish Trend 3 days ago
74%
Bullish Trend 3 days ago
78%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
66%
Bullish Trend 3 days ago
75%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
68%
Bearish Trend 3 days ago
87%
Advances
ODDS (%)
Bullish Trend 6 days ago
79%
N/A
Declines
ODDS (%)
Bearish Trend 26 days ago
66%
Bearish Trend 25 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
84%
N/A
Aroon
ODDS (%)
Bearish Trend 3 days ago
48%
Bearish Trend 3 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
AXON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CVAC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MNDCX15.960.16
+1.01%
MFS New Discovery C
VREQX10.440.10
+0.97%
NYLI CBRE Real Estate Class R6
TSMDX15.710.15
+0.96%
Trillium ESG Small/Mid Cap Institutional
PXSCX18.610.16
+0.87%
Impax Small Cap Investor
DFSIX51.060.35
+0.69%
DFA US Sustainability Core 1

CVAC and

Correlation & Price change

A.I.dvisor indicates that over the last year, CVAC has been loosely correlated with AIM. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if CVAC jumps, then AIM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CVAC
1D Price
Change %
CVAC100%
+0.37%
AIM - CVAC
44%
Loosely correlated
-6.94%
MRNA - CVAC
39%
Loosely correlated
-0.49%
AXON - CVAC
39%
Loosely correlated
-0.46%
BNTX - CVAC
36%
Loosely correlated
N/A
VOR - CVAC
35%
Loosely correlated
-0.56%
More